Gliesse Pharmaceuticals Private Limited

Manufactures pharmaceuticals, medicinal chemicals, and botanical products since 2020 in Gujarat.

2020 | Ahmedabad, Gujarat (India) | Active
Last Updated:

Gliesse Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 1.00 M
  • Company Age 4 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth 451.90%
  • Profit Growth 859.98%
  • Ebitda 1402.81%
  • Net Worth 267.36%
  • Total Assets -25.42%

About Gliesse Pharmaceuticals

Gliesse Pharmaceuticals Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 August 2020 (Four years and seven months 21 days old ). Its registered office is in Ahmedabad, Gujarat, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.

Ruchi Shah, Jatinbhai Shah, Neel Shah, and One other member serve as directors at the Company.

Company Details

  • Location

    Ahmedabad, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24110GJ2020PTC115404

  • Company No.

    115404

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    08 Aug 2020

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

Who are the key members and board of directors at Gliesse Pharmaceuticals?

Board Members (4)

NameDesignationAppointment DateStatus
Neel Shah Country flag representing In Director 08-Aug-2020Current
Ruchi Shah Country flag representing In Director 01-Jan-2024Current
Jatinbhai Shah Country flag representing In Director 08-Aug-2020Current
Mitaben Vakil Country flag representing In Director 01-Jan-2024Current

Financial Performance of Gliesse Pharmaceuticals.

Gliesse Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 451.9% increase. The company also saw a substantial improvement in profitability, with a 859.98% increase in profit. The company's net worth Soared by an impressive increase of 267.36%.

Gliesse Pharmaceuticals revenue growth over time
Gliesse Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
451.90%
Revenue from Operations
454.91%
Total Assets
-25.42%
Profit or Loss
859.98%
Net Worth
267.36%
EBITDA
1402.81%

What is the Ownership and Shareholding Structure of Gliesse Pharmaceuticals?

Unlock access to Gliesse Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Gliesse Pharmaceuticals?

Gliesse Pharmaceuticals has a workforce of 0 employees as of Mar 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Gliesse Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gliesse Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gliesse Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Gliesse Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Gliesse Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Gliesse Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.

  • Director Appointment

    Ruchi Darshan Shah was appointed as a Director was appointed as a Director on 01 Jan 2024 & has been associated with this company since 1 year 2 months .

  • Director Appointment

    Mitaben Dineshbhai Vakil was appointed as a Director was appointed as a Director on 01 Jan 2024 & has been associated with this company since 1 year 2 months .

  • Director Appointment

    Jatinbhai Siddharthbhai Shah was appointed as a Director was appointed as a Director on 08 Aug 2020 & has been associated with this company since 4 years 7 months .

  • Director Appointment

    Neel Hetal Shah was appointed as a Director was appointed as a Director on 08 Aug 2020 & has been associated with this company since 4 years 7 months .

Frequently asked questions

  • What is the Incorporation or founding date of Gliesse Pharmaceuticals Private Limited?

    Gliesse Pharmaceuticals Private Limited was incorporated on 08 Aug 2020.

  • What is authorized share capital and paid-up capital of Gliesse Pharmaceuticals Private Limited?

    The authorized share capital of Gliesse Pharmaceuticals Private Limited is ₹ 1.00 Cr and paid-up capital is ₹ 1.00 M.

  • Who are the current board members & directors of Gliesse Pharmaceuticals Private Limited?

    Currently 4 directors are associated with Gliesse Pharmaceuticals Private Limited.

    • Ruchi Darshan Shah
    • Jatinbhai Siddharthbhai Shah
    • Neel Hetal Shah
    • Mitaben Dineshbhai Vakil
  • What is the registered address of Gliesse Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Gliesse Pharmaceuticals Private Limited is 10Th Floor Shop No. 1007 Atlantis Prahlad Nagar Road, Satellite India, Ahmedabad, Gujarat, 380015.

  • What is the corporate identification number (CIN) and company number of Gliesse Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Gliesse Pharmaceuticals Private Limited is U24110GJ2020PTC115404 and the company number is 115404 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Gliesse Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2024, the revenue trend for Gliesse Pharmaceuticals Private Limited has risen by 451.90%.

  • What change has been observed in the net worth of Gliesse Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2024 indicates that The net worth of Gliesse Pharmaceuticals Private Limited has experienced an upsurge of 267.36%.

  • When was the last Balance Sheet of Gliesse Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Gliesse Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.